SEC Filings

Filing date Form Description View
SC TO-I/A

Amendment to a previously filed SC TO-I

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
3

Initial filing by director officer or owner of more than ten percent.

View HTML
CORRESP

CORRESP

View HTML
UPLOAD

UPLOAD

View HTML
SC TO-I

Tender offer schedule and amendment filed by the issuer.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
SC 13D/A

An amendment to a SC 13D filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

 

 

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools